Lung Cancer

Predicting Lung Cancer Risk of Incidental Solid and Subsolid Pulmonary Nodules in Different Sizes

Publish Date September 25, 2020

[Cancer Management and Research] Based on these study findings, researchers present 4 prediction models developed to determine risk of malignancy in subsolid and solid lung nodules that are 15 mm or smaller and 15 to 30 mm.

Immunotherapy Plus Radiotherapy After Surgery Improves OS in Tumors With Brain Metastases, Study Finds

By

Rick Maffei

Publish Date September 23, 2020

Study found adding immunotherapy to radiotherapy significantly improved OS after definitive surgery for primary tumor in patients with brain metastasis.

E-Cigarette Use Increased Significantly From 2017 to 2018

Publish Date September 15, 2020

From 2016 to 2018, there was also an increase in daily use, sole e-cigarette use.

Immunotherapy for the Treatment of Melanoma and Lung Cancer

By

Sheila G. Gwinn, RN, BSN

Publish Date September 13, 2020

Immunotherapy has improved outcomes for patients with cancer, despite several drawbacks. This review provides an overview of how to manage patients undergoing therapy with these drugs.

Gavreto Approved for Metastatic RET Fusion-Positive NSCLC

By

Brian Park, PharmD

Publish Date September 11, 2020

The FDA has approved Gavreto™ (pralsetinib; Blueprint Medicines and Genentech) for the treatment of adults with metastatic RET fusion-positive NSCLC.

Lung Cancer Clinical Trials

Clinical Trial: Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer

Clinical Trial: Improving Management of Breathlessness in Patients With Lung Cancer

Clinical Trial: Lung Cancer Screening Study With Low-dose CT Scan and Blood Biomarker

Clinical Trial: Lung Cancer Biomarkers and Screening (NYULCBC)

Clinical Trial: Proton Therapy for Stage I Non-Small Cell Lung Cancer (LU03)